However, the relationship between CML stem cells and TFR is still controversial, as there is a report that CML stem cells can be detected in the peripheral blood of patients during successful TKI discontinuation [31]. The gene discussed is TFRC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.